Rocket Pharmaceuticals, Inc. Share Price
NASDAQ: RCKT | Micro CapRocket Pharmaceuticals, Inc. Stock Performance
Rocket Pharmaceuticals, Inc. Share Price Today
As of 9 October 2026, Rocket Pharmaceuticals, Inc.'s share price is $2.63. The stock opened at $2.77, compared to its previous close of $2.56. During today's trading session, Rocket Pharmaceuticals, Inc.'s share price traded between $2.52 and $2.77, with an average price of $2.65. Over the past 52 weeks, the stock has recorded a high of $5.45 and a low of $2.42. In terms of performance, Rocket Pharmaceuticals, Inc.'s share price has declined by 24.79% over the last six months and is down 30.37% on a year-on-year basis.
Rocket Pharmaceuticals, Inc. Share Price Chart
Rocket Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Rocket Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Rocket Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.63 | $2.65 | +0.38% |
Sep 2026 | $3.70 | $2.63 | -27.21% |
Aug 2026 | $3.13 | $3.62 | +16.03% |
Jul 2026 | $3.50 | $3.12 | -9.04% |
Jun 2026 | $3.04 | $3.43 | +11.73% |
May 2026 | $3.46 | $3.07 | -12.03% |
Apr 2026 | $3.64 | $3.49 | -2.51% |
Mar 2026 | $4.95 | $3.58 | -28.69% |
Feb 2026 | $3.40 | $5.02 | +44.67% |
Jan 2026 | $3.49 | $3.47 | -1.14% |
Dec 2025 | $3.29 | $3.51 | +2.48% |
Nov 2025 | $3.75 | $3.42 | -9.15% |